Delivery Order SPE2DB22D3401-SPE2DB26FT0QU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $54,419.28 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Voranigo 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $54,189.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Voranigo 40 mg tablets (30-count units), with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price contract, designated as a non-competitive, non-set-aside award, is scheduled for completion by November 28, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $54,189.90. The contract, which became effective on May 2, 2025, with an ultimate completion date of May 23, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a $27,094.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $76,246.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Voranigo 10 mg tablets (30-count packages). The contract, which is non-set-aside and competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 14, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0QUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $81,284.85 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on November 5, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this order under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This delivery order represents one of numerous pharmaceutical product acquisitions that AmerisourceBergen executes through its DLA prime contract vehicle, which enables the company to supply a broad range of medications, vaccines, and medical supplies to support military and federal healthcare systems worldwide. The contract demonstrates the vendor's established capability to meet federal procurement requirements for specialized pharmaceutical products through open competition, supporting critical healthcare operations across the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.3k | 11/5/25 |